5
Orphan Designations
0
FDA Approvals
8
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| acute flaccid myelitis | Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc) | Orphan Designation | - |
| acute lymphoblastic leukemia | Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc) | Orphan Designation | - |
| acute radiation syndrome | Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc) | Orphan Designation | - |
| glioma susceptibility 1 | Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc). | Orphan Designation | - |
| idiopathic | Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc) | Orphan Designation | - |
| idiopathic CD4 lymphocytopenia | Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc) | Orphan Designation | - |
| idiopathic CD4-positive T-lymphocytopenia | Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc) | Orphan Designation | - |
| progressive multifocal leukoencephalopathy | Recombinant human interleukin-7 fused to a hybrid crystallizable fragment region of a human antibody (rhIL-7-hyFc). | Orphan Designation | - |